Researchers at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), reporting this week in the journal Proceedings of the National Academy of Sciences, identified a mechanism through which two antiviral genes, when mutated, promote a childhood cancer called pediatric myelodysplastic syndrome (MDS). Scientists at Oklahoma State University and Cornell University collaborated […]

  Approximately 30% of individuals with myeloid malignancy diseases have a mutation in a certain gene called tet methylcytosine dioxygenase 2 (TET2). This gene is responsible for providing instructions on creating certain proteins and is known to have a tumor-suppressive function. A study published October 2 in Nature is the first to explain the pathway […]

Ruben A. Mesa, MD, FACP, executive director of the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, has played a key role as both an investigator and aiding the drug development for the past eight years to get RoPEG INFa2b (besremi) approved in PV.

Yu Luan, PhD, assistant professor in the Department of Cell Systems and Anatomy in the Joe R. and Teresa Lozano Long School of Medicine at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) received a UT System Rising STARs (Science and Technology Acquisition and Retention) award in the amount […]

Discover how genetic testing at the Mays Cancer Center can guide cancer prevention and treatment. Learn about DNA analysis, personalized risk management, and family implications, as our expert counselors support your journey to proactive, informed cancer care.

Mays Cancer Center researchers are making significant strides in understanding risk factors and conditions that cause cancers to develop and progress and assessing impacts on the health and recovery of patients with cancer.

Colorectal cancer begins in the colon or rectum and typically develops slowly over several years, starting as small, noncancerous growths called

The findings from recent research studies in pediatric cancer offer hope for drug development.

The Mays Cancer Center is testing new treatments to enhance and extend the life of patients with cancer and translating leading-edge research into new drugs and technology-assisted procedures that are improving patient health and recovery.

Explore beyond basil's culinary charm into its therapeutic potential for patients with cancer. Discover how its antioxidants, anti-inflammatory compounds, immune-boosting nutrients, and stress-reducing properties can complement treatments. Learn easy ways to incorporate basil into meals, like a delectable basil pesto recipe.